Optimal duration of olanzapine add-on therapy in major depression: a placebo-controlled, randomized, phase III, pilot study in parallel group design.
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 31 Mar 2012
At a glance
- Drugs Olanzapine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- Acronyms OLA-D
- 26 Apr 2008 Status changed from recruiting to withdrawn prior to recruitment.
- 24 Dec 2007 New trial record.